Brain Drain And Recruitment Risks for EMA post UK Brexit Vote
Retaining existing and recruiting new staff could be a challenge for the London-based European Medicines Agency as a result of the uncertainty over the future location of the agency following the decision by the UK to leave the EU.
You may also be interested in...
Brexit: EMA Could Lose Up To Half Its Staff If It Has To Move
The European Medicines Agency is working to ensure it can cope with the many challenges it will face as a result of the UK leaving the EU. Those challenges could include the agency losing 50% of its staff, according to the EMA’s deputy head Noel Wathion.
Brexit: EMA To Bolster Regulatory Reserves Ahead Of Relocation
European Medicines Agency head Guido Rasi explains the measures being taken to soften the blow of its departure from the UK, while a former health commissioner says that a decision needs to be taken as soon as possible on where the agency will be sited in order to ensure a smooth transition before Brexit.
Japan Wants EMA To Stay In UK Post-Brexit
The assumption to date has been that the European Medicines Agency will have to relocate from London to another EU member state when the UK leaves the EU. Japan says it should stay. Also, Emer Cooke, the EMA’s head of international affairs, is leaving the agency.